Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-18 Gardiner Nathaniel S. Sr. VP & General Counsel Option exercise +6,667 $30.00 $200K 79,980
2023-04-18 Gardiner Nathaniel S. Sr. VP & General Counsel Option exercise · Stock Option (Right to Buy) −6,667 7,000
2023-03-16 Vance Terry Director Option exercise +5,800 $14.00 $81K 21,095
2023-03-16 Vance Terry Director Option exercise · Stock Option (right to buy) −5,800 0
2023-03-15 MELLETT PAUL J Treasurer and CFO Option exercise +10,440 $14.00 $146K 107,996
2023-03-15 MELLETT PAUL J Treasurer and CFO Sale −100 $43.96 $4K 107,896
2023-03-15 MELLETT PAUL J Treasurer and CFO Sale −10,340 $44.43 $459K 97,556
2023-03-15 MELLETT PAUL J Treasurer and CFO Option exercise · Stock Option (Right to Buy) −10,440 0
2023-03-15 Or Yat Sun Sr. VP & CSO Option exercise +13,925 $14.00 $195K 388,627
2023-03-15 Or Yat Sun Sr. VP & CSO Sale −269 $43.92 $12K 388,358
2023-03-15 Or Yat Sun Sr. VP & CSO Sale −13,656 $44.46 $607K 374,702
2023-03-15 Or Yat Sun Sr. VP & CSO Option exercise · Stock Option (Right to Buy) −13,925 0
2023-03-13 Luly Jay R. President and CEO Option exercise +27,912 $14.00 $391K 847,722
2023-03-13 Luly Jay R. President and CEO Sale −10,697 $44.81 $479K 837,025
2023-03-13 Luly Jay R. President and CEO Sale −15,649 $45.31 $709K 821,376
2023-03-13 Luly Jay R. President and CEO Sale −1,566 $46.13 $72K 819,810
2023-03-13 Luly Jay R. President and CEO Option exercise · Stock Option (Right to Buy) −27,912 0
2023-03-02 Vance Terry Director Grant or award · Stock Option (right to buy) +10,800 10,800
2023-03-02 Russell Lesley Director Grant or award · Stock Option (right to buy) +10,800 10,800
2023-03-02 Peterson Kristine Director Grant or award · Stock Option (right to buy) +10,800 10,800

Page 8 of 19 · 377 trades